Estrogen and Psychosis - a Review and Future Directions

Overview

Journal Arch Womens Ment Health

Publisher Springer

Specialties Gynecology & Obstetrics
Psychiatry
Psychology

Date 2024 Jan 14

PMID 38221595

Authors

Eveline Mu

Caroline Gurvich

Jayashri Kulkarni

Affiliations

Soon will be listed here.

Abstract

The link between sex hormones and schizophrenia has been suspected for over a century; however, scientific evidence supporting the pharmacotherapeutic effects of exogenous estrogen has only started to emerge during the past three decades. Accumulating evidence from epidemiological and basic research suggests that estrogen has a protective effect in women vulnerable to schizophrenia. Such evidence has led multiple researchers to investigate the role of estrogen in schizophrenia and its use in treatment. This narrative review provides an overview of the effects of estrogen as well as summarizes the recent work regarding estrogen as a treatment for schizophrenia, particularly the use of new-generation selective estrogen receptor modulators.

Citing Articles

An Evaluation of a Women's Clinic: The Healthcare and Learning Project of the Functional Unit for Women with Schizophrenia.

Gonzalez-Rodriguez A, Natividad M, Palacios-Hernandez B, Ayesa-Arriola R, Cobo J, Monreal J Healthcare (Basel). 2024; 12(15).

PMID: 39120186 PMC: 11312130. DOI: 10.3390/healthcare12151483.

References

Adams M, Shah R, Janssen W, Morrison J . Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc Natl Acad Sci U S A. 2001; 98(14):8071-6. PMC: 35469. DOI: 10.1073/pnas.141215898. View

Alosaimi F, Fallata E, Abalhassan M, Alhabbad A, Alzain N, Alhaddad B . Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications. Int J Psychiatry Clin Pract. 2018; 22(4):274-281. DOI: 10.1080/13651501.2018.1425459. View

Arevalo M, Santos-Galindo M, Bellini M, Azcoitia I, Garcia-Segura L . Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta. 2009; 1800(10):1106-12. DOI: 10.1016/j.bbagen.2009.10.002. View

Arevalo M, Santos-Galindo M, Lagunas N, Azcoitia I, Garcia-Segura L . Selective estrogen receptor modulators as brain therapeutic agents. J Mol Endocrinol. 2010; 46(1):R1-9. DOI: 10.1677/JME-10-0122. View

Bahner F, Meyer-Lindenberg A . Hippocampal-prefrontal connectivity as a translational phenotype for schizophrenia. Eur Neuropsychopharmacol. 2017; 27(2):93-106. DOI: 10.1016/j.euroneuro.2016.12.007. View

Balthazart J, Ball G . Is brain estradiol a hormone or a neurotransmitter?. Trends Neurosci. 2006; 29(5):241-9. DOI: 10.1016/j.tins.2006.03.004. View

Begemann M, Dekker C, Van Lunenburg M, Sommer I . Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophr Res. 2012; 141(2-3):179-84. DOI: 10.1016/j.schres.2012.08.016. View

Brand B, de Boer J, Sommer I . Estrogens in schizophrenia: progress, current challenges and opportunities. Curr Opin Psychiatry. 2021; 34(3):228-237. PMC: 8048738. DOI: 10.1097/YCO.0000000000000699. View

Brann D, Lu Y, Wang J, Zhang Q, Thakkar R, Sareddy G . Brain-derived estrogen and neural function. Neurosci Biobehav Rev. 2021; 132:793-817. PMC: 8816863. DOI: 10.1016/j.neubiorev.2021.11.014. View

Lee B, Kim Y . The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(4):658-62. DOI: 10.1016/j.pnpbp.2005.11.037. View

Bryant D, Dorsa D . Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity. Neuroscience. 2010; 170(4):1261-9. PMC: 2949441. DOI: 10.1016/j.neuroscience.2010.08.019. View

10.

Kulkarni J, Gavrilidis E, Worsley R, Hayes E . Role of estrogen treatment in the management of schizophrenia. CNS Drugs. 2012; 26(7):549-57. DOI: 10.2165/11630660-000000000-00000. View

10.

Buckley P . Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat. 2008; 1(3):193-204. PMC: 2416751. View

11.

Cohen R, Seeman M, Gotowiec A, Kopala L . Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry. 1999; 156(7):1059-64. DOI: 10.1176/ajp.156.7.1059. View

12.

Dabbous Z, Atkin S . Hyperprolactinaemia in male infertility: Clinical case scenarios. Arab J Urol. 2018; 16(1):44-52. PMC: 5922222. DOI: 10.1016/j.aju.2017.10.002. View

13.

Dabiri M, Dehghani Firouzabadi F, Yang K, Barker P, Lee R, Yousem D . Neuroimaging in schizophrenia: A review article. Front Neurosci. 2022; 16:1042814. PMC: 9706110. DOI: 10.3389/fnins.2022.1042814. View

14.

Damme K, Ristanovic I, Vargas T, Mittal V . Timing of menarche and abnormal hippocampal connectivity in youth at clinical-high risk for psychosis. Psychoneuroendocrinology. 2020; 117:104672. PMC: 7305941. DOI: 10.1016/j.psyneuen.2020.104672. View

15.

Kianimehr G, Fatehi F, Hashempoor S, Khodaei-Ardakani M, Rezaei F, Nazari A . Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial. Daru. 2014; 22:55. PMC: 4100751. DOI: 10.1186/2008-2231-22-55. View

15.

Diotel N, Vaillant C, Gabbero C, Mironov S, Fostier A, Gueguen M . Effects of estradiol in adult neurogenesis and brain repair in zebrafish. Horm Behav. 2012; 63(2):193-207. DOI: 10.1016/j.yhbeh.2012.04.003. View

16.

Gonzalez-Rodriguez A, Labad J, Seeman M . Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 101:109941. DOI: 10.1016/j.pnpbp.2020.109941. View